📰 Cm Management News
Cm Management News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cm Management. Real-time updates on events, politics, business and more.
June 3, 2024
Cytosorbents Co. (NASDAQ:CTSO – Get Free Report) was the recipient of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 1,460,000 shares, a decrease of 5.8% from the April 30th total of 1,550,000 shares. Based on an average trading volume of 102,400 shares, the […]
May 30, 2024
StockNews.com began coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research note issued to investors on Sunday. The firm issued a hold rating on the medical research company’s stock. Several other equities analysts have also issued reports on CTSO. B. Riley reissued a buy rating and set a $3.00 target price on […]
May 29, 2024
EverSource Wealth Advisors LLC increased its stake in shares of Barrick Gold Corp (NYSE:GOLD – Free Report) (TSE:ABX) by 175.6% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,794 shares of the gold and copper producer’s stock after acquiring an additional 1,143 shares during the period. […]
May 29, 2024
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 191,500 shares, a growth of 441.0% from the April 30th total of 35,400 shares. Based on an average daily trading volume, of 185,700 shares, the days-to-cover […]
May 28, 2024
HC Wainwright reissued their buy rating on shares of Coherus BioSciences (NASDAQ:CHRS – Free Report) in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has a $12.00 price target on the biotechnology company’s stock. Separately, Truist Financial cut their price target on shares of Coherus BioSciences from $8.00 to $7.00 […]
May 28, 2024
Shares of DURECT Co. (NASDAQ:DRRX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the five analysts that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price […]
May 27, 2024
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Trading Down 0.1 % Shares of PIRS stock opened at $10.48 on Thursday. Pieris Pharmaceuticals has a twelve month low of $10.31 and […]
May 27, 2024
Pan American Silver (NYSE:PAAS – Free Report) (TSE:PAAS) had its price target hoisted by Scotiabank from $20.00 to $23.00 in a research note issued to investors on Thursday morning, Benzinga reports. Scotiabank currently has a sector outperform rating on the basic materials company’s stock. Other equities research analysts have also issued reports about the stock. […]
May 26, 2024
StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Down 0.1 % NASDAQ PIRS opened at $10.48 on Thursday. The business’s 50-day moving average price is $12.87 and […]
May 26, 2024
StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance PIRS stock opened at $10.48 on Thursday. The firm has a market cap of $13.83 million, a price-to-earnings ratio of […]